Source: Eur Respir J, 50 (1) 1700946; 10.1183/13993003.00946-2017
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Mario Raviglione, Vladimir Poznyak. Targeting harmful use of alcohol for prevention and treatment of tuberculosis: a call for action. Eur Respir J, 50 (1) 1700946; 10.1183/13993003.00946-2017

Member's Comments

No comment yet.

Related content which might interest you: Effects of novel tobacco and nicotine products on lung health: use and misuse of the evidence Source: International Congress 2019 – E-cigarettes and heated tobacco: a blessing or a curse? The latest scientific update Year: 2019 Nicotine and cannabis use among teenagers: from prevention to treatment. What works? Source: Virtual Congress 2021 – Orphan childhood disease: nicotine and cannabis addiction Year: 2021 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 571-574 Year: 2015 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 569-571 Year: 2015 Rational use of tuberculosis drugs to prevent the development of drug resistance Source: Annual Congress 2012 - MDR- and XDR-TB: epidemiological and public health overview Year: 2012 Should tobacco discontinuation be part of tuberculosis control program? Source: Annual Congress 2010 - Tuberculosis: metabolic insights Year: 2010 The treatment of tobacco dependence: an effective treatment for COPD Source: Annual Congress 2012 - Treatment of tobacco dependence as a treatment of lung diseases Year: 2012 Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013 Tobacco and tuberculosis: could we improve tuberculosis outcomes by helping patients to stop smoking? Source: Eur Respir J 2015; 45: 583-585 Year: 2015 Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases? Source: Eur Respir J 2009; 33: 468-480 Year: 2009 The effect of alcohol use on course of tuberculosis disease Source: Annual Congress 2003 - Clinical aspects of tuberculosis Year: 2003 Reasons for hepatotoxic reactions to chemotherapeutic agents and possibilities of their prevention in adolescents with tuberculosis Source: Eur Respir J 2001; 18: Suppl. 33, 468s Year: 2001 The treatment of tobacco dependence: an effective treatment for lung cancer Source: Annual Congress 2012 - Treatment of tobacco dependence as a treatment of lung diseases Year: 2012 Vitamin C against the harmful effects of prenatal passive smoking: when all other options fail? Source: Eur Respir J, 56 (6) 2002770; 10.1183/13993003.02770-2020 Year: 2020 Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources Source: Eur Respir J 2006; 28: Suppl. 50, 28s Year: 2006 Antituberculosis drug-induced hepatotoxicity: influence on the management and outcome of active tuberculosis (TB) Source: Annual Congress 2007 - Epidemiology of tuberculosis II Year: 2007 Consuming alcohol among tuberculosis patients and the influence to therapy Source: Eur Respir J 2007; 30: Suppl. 51, 423s Year: 2007 Smoking prevention and smoking cessation. Are we targeting the right population? Source: Eur Respir J 2002; 20: Suppl. 38, 610s Year: 2002 Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention Source: Virtual Congress 2020 – Reducing the burden of asthma Year: 2020 Impact of awareness-raising and screening actions in tobacco use Source: Annual Congress 2008 - Smoking cessation and new tobacco uses Year: 2008